Daiichi Sankyo Company, Limited, today obtained manufacturing and marketing approval in Japan for new formulations of Cravit (Levofloxacin Hydrate), a broad-spectrum oral anti-bacterial agent. These formulations are 250mg and 500mg tablets, and a 10% fine granular preparation.
The details can be read here.
No comments:
Post a Comment